Revolutionizing Cancer Screening: The Impact of Multi-Cancer Blood Tests
Explore how innovative blood tests like Galleri could transform cancer screening practices and insurance coverage in the U.S. early detection strategies.
OIG Advisory Opinion on Cancer Detection Reports: Key Insights
Discover the latest OIG Advisory Opinion clarifying cancer detection practices and compliance. Learn valuable insights for healthcare companies on regulatory navigation.
Navigating the Diagnostic Gap in Precision Medicine
Explore the critical diagnostic gaps in precision medicine and how insurance coverage impacts patient access to essential tests, preventing effective treatment.
HHS Advances Lyme Disease Diagnostics and Patient Care with LymeX Renewal
HHS renews LymeX Innovation Accelerator to boost AI-driven diagnostics and expands Medicare support for Lyme disease patients, advancing national care strategies.
Exact Sciences’ Growth Potential Bolstered by Cologuard Plus and Medicare Advantage Expansion
Exact Sciences gains Buy ratings as Cologuard Plus expands in-network Medicare Advantage coverage, boosting reimbursement and revenue potential in cancer screening diagnostics.
Supreme Court Upholds ACA Preventive Care Coverage, Influencing Healthcare Investments
The Supreme Court's 2025 ruling affirms ACA preventive service coverage, shaping pharmaceutical, diagnostic, and insurance sector investments amid evolving HHS regulations.